Teelucksingh Siara, Murali Govind Renuka, Dobson Ruth, Nelson-Piercy Catherine, Ovadia Caroline
Department of Obstetric Medicine, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Preventive Neurology Unit, Queen Mary University of London, London, UK.
Int J Womens Health. 2023 Feb 16;15:321-338. doi: 10.2147/IJWH.S371491. eCollection 2023.
Vestibular migraine is a leading cause of vertigo in pregnancy and, although not a distinct migraine subtype, is an episodic syndrome associated with migraine. Vestibular migraine is associated with diverse symptoms such as vertigo, aura, allodynia, osmophobia, nausea, vomiting and tinnitus, many of which may be exacerbated by, masked or even dismissed in pregnancy. Vestibular migraine is likely an underdiagnosed and undertreated condition in pregnancy. The aetiology of vestibular migraine remains incompletely understood, although various theories have been proposed, including genetic predisposition, neurochemical dysregulation and pro-inflammatory mechanisms, all of which are derived from the pathophysiology of classical migraine. Physiologic changes to the endocrine, haematologic and vascular systems in pregnancy may affect pathophysiological processes in vestibular migraine, and can alter the course of symptoms experienced in pregnancy. These changes also predispose to secondary headache disorders, which may have similar presentations. There has been considerable progress in therapeutic advances in vestibular migraine prophylaxis and treatment outside of pregnancy. There is currently no significant evidence base for acute treatment or prophylaxis for pregnant patients, with treatment recommendations extrapolated from studies on classical migraine, and offered on a benefit versus risk basis. Challenges commonly encountered include difficulty establishing a diagnosis, in addition to recognising and treating neuropsychiatric and gestational co-morbidities. Anxiety, depression, hypertensive disorders and cardiovascular disease are closely associated with migraine, and important contributors to morbidity and mortality during pregnancy. Identifying and treating vestibular migraine during pregnancy offers a unique opportunity to impact future patient health through screening and early treatment of associated co-morbidities. There have been innovations in classical migraine therapy that may confer benefit in vestibular migraine in pregnancy, with emphasis on lifestyle modification, effective prophylaxis, abortive therapies, cognitive behaviour therapy and management of vestibular migraine-related comorbidities.
前庭性偏头痛是妊娠期眩晕的主要原因,尽管它不是一种独特的偏头痛亚型,但却是一种与偏头痛相关的发作性综合征。前庭性偏头痛与多种症状相关,如眩晕、先兆、痛觉过敏、恐嗅症、恶心、呕吐和耳鸣,其中许多症状在孕期可能会加重、被掩盖甚至被忽视。前庭性偏头痛在妊娠期可能是一种诊断不足和治疗不足的疾病。尽管已经提出了各种理论,包括遗传易感性、神经化学失调和促炎机制,但前庭性偏头痛的病因仍未完全明确,所有这些理论都源于经典偏头痛的病理生理学。妊娠期内分泌、血液和血管系统的生理变化可能会影响前庭性偏头痛的病理生理过程,并可能改变孕期经历的症状过程。这些变化还易引发继发性头痛疾病,其表现可能相似。在妊娠期以外的前庭性偏头痛预防和治疗方面,治疗进展取得了相当大的进展。目前尚无针对孕妇急性治疗或预防的重要证据基础,治疗建议是从经典偏头痛的研究中推断出来的,并基于获益与风险的基础上提供。常见的挑战包括难以确立诊断,此外还包括识别和治疗神经精神和妊娠合并症。焦虑、抑郁、高血压疾病和心血管疾病与偏头痛密切相关,是孕期发病和死亡的重要因素。在孕期识别和治疗前庭性偏头痛,为通过筛查和早期治疗相关合并症来影响未来患者健康提供了一个独特的机会。经典偏头痛治疗方面已有创新,可能对妊娠期前庭性偏头痛有益,重点是生活方式改变、有效预防、中止治疗、认知行为疗法以及前庭性偏头痛相关合并症的管理。